Article
Etoposide damages female germ cells in the developing ovary
15 Jul 2016
Abstract excerpt
BACKGROUND: As with many anti-cancer drugs, the topoisomerase II inhibitor etoposide is considered safe for administration to women in the second and third trimesters of pregnancy, but assessment of effects on the developing fetus have been limited. The purpose of this research was to examine the effect of etoposide on germ cells in the developing ovary. Mouse ovary tissue culture was used as the experimental...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
